Urinary Fibrin/Fibrinogen Derivatives^[*]

 

^* Presented at the Postgraduate Course and Workshop “Progress in Fibrinolysis”, Milano, Italy, March 6–8, 1975.

• References

• 1 Allington M. J. 1971; Detection of fibrin(ogen) degradation products by a latex clumping method. Scandinavian Journal of Haematology Suppl.13: 115.
• 2 Ambbjjs J. L, Baliah T, Ambrus C. M, Mink I. B, and Murphy G. P. 1974 Fibrin-fibrinogen degradation products in children with renal disease. New York State Journal of Medicine, July 1974, p. 1396.
• 3 Antoine B, Neveu Th, and Ward P. D. 1969; Fibrinuria during renal transplantation. Transplantation 8: 98.
• 4 Åstedt B, and Pandolfi M. 1971; Ontogenesis of tissue plasminogen activator in the human. Thrombosis et Diathesis Haemorrhagica 25: 469.
• 5 Åstedt B, and Pandolfi M. 1972; On release and synthesis of fibrinolytic activators in human organ culture. Revue Européenne d’Études Cliniques et Biologiques 17: 261.
• 6 Bacani R. A, Velasquez F, Kanter A, Pirani C. L, and Pollak V. E. 1968; Rapidly progressive (nonstreptococcal) glomerulonephritis. Annals of Internal Medicine 69: 463.
• 7 Bennett N. M, Bennett D, Holland N. H, and Luke R. G. 1972; Serum fibrin degradation products in the diagnosis of transplantation rejection. Transplantation 14: 311.
• 8 Bernik M. B, and Kwaan H. C. 1967; Origin of fibrinolytic activity in cultures of the human kidney. The Journal of Laboratory and Clinical Medicine 70: 650.
• 9 Boomgaard J, Vreeken J, Bleyenberg A, and Deggeller K. 1969; Studies on urokinase. Some physiological considerations concerning normal urokinase excretion. Clinica Chimica Acta 13: 484.
• 11 Bouma B. N, Hedner U, and Nilsson I. M. 1971; Typing of fibrinogen degradation products in urine in various clinical disorders. The Scandinavian Journal of Clinical & Laboratory Investigation 27: 331.
• 12 Braun W. E, and Merrill J. P. 1968; Urine fibrinogen fragments in human renal allografts. New England Journal of Medicine 278: 1366.
• 13 Briggs J. D, Prentice C. R. M, Hutton M. M, Kennedy A. C, and McNicol G. P. 1972; Serum and urine fibrinogen-fibrin-related antigen (F. R.-antigen) levels in renal disease. British Medical Journal 4: 82.
• 14 Carlsson S, Hedner U, Nilsson I. M, Bergentz S.-E, and Ljungqvist U. 1970; Kidney transplantation and fibrinolytic split products in serum and urine. Transplantation 10: 366.
• 15 Cash J. D, and Clarkson A. R. 1971; Serum and urinary fibrin/fibrinogen degradation products in renal disease. Scandinavian Journal of Haematology Suppl.13: 331.
• 16 Chirawong P, Singh Nanra R, and Kincaid-Smith P. 1971; Fibrin degradation products and the role of coagulation in “persistent” glomerulonephritis. Annals of Internal Medicine 74: 853.
• 17 Claes G, Svalander C, and Bergentz S.-E. 1973; The accumulation and distribution of platelets and fibrin in rejecting dog kidneys. Acta Chirurgica Scandinavica 139: 91.
• 18 Clarkson A. R, MacDonald M.K, Petrie J. J. B, Cash J. D, and Robson J. S. 1971; Serum and urinary fibrin/fibrinogen degradation products in glomerulonephritis. British Medical Journal 3: 447.
• 19 Clarkson A. R, Morton J. B, and Cash J. D. 1970; Urinary fibrin/fibrinogen degradation products after renal homotransplantation. Lancet 2: 1220.
• 20 Cortes P, Potter E. V, and Kwaan H. C. 1973; Characterization and. significance of urinary fibrin degradation products. Journal of Laboratory and Clinical Medicine 82: 377.
• 21 Davison A. M, Thomson D, MacDonald M. K, Rae J. K, Uttley W. S, and Clarkson A. R. 1973; Identification of intrarenal fibrin deposition. Journal of Clinical Pathology 26: 102.
• 22 Donati M. B, Semeraro N, and Vermylen J. 1973; Detection of fibrinogen antigens with two latex techniques applied to urine concentrates. Journal of Clinical Pathology 26: 760.
• 23 Donati M. B, Vermylen J, and Verstraete M. 1971; The staphylococcal clumping test for detection of fibrinogen-like material. Scandinavian Journal of Haematology Suppl.13: 137.
• 24 Edward N, Young D. P.-G, and MacLeod M. 1964; Fibrinolytic activity in plasma and urine in chronic renal disease. Journal of Clinical Pathology 17: 365.
• 25 Ekberg M, Bergentz S.-E, Hedner U, and Nilsson I. M. 1975 Fibrin/fibrinogen degradation products (FDP) and renal transplantation. Scandinavian Journal of Urology and Nephrology. In press.
• 26 Ekberg M, Nilsson I. M, Hedner U, and Nosslin B. 1975; A radioimmunoassay for determination of urinary fibrin/fibrinogen degradation products. 2: 17.
• 27 Ekberg M, and Pandolfi M. 1975 On the origin of urinary fibrin/fibrinogen degradation products in glomerulonephritis. British Medical Journal. In press.
• 28 Ekert H, Barratt T. M, Chantler C, and Turner M. W. 1972; Immunologically reactive equivalents of fibrinogen in sera and urine of children with renal disease. Archives of Disease in Childhood 47: 90.
• 29 Franklin W. A, Simon N. M, Potter E. W, and Krumlovsky F. A. 1972; The hemolytic-uremic syndrome. Archives of Pathology 94: 230.
• 30 Garvey M. B, and Black J. M. 1972; The detection of fibrinogen/fibrin degradation products by means of a new antibody-coated latex particle. Journal of Clinical Pathology 25: 680.
• 31 George C. R. P, Slichter S. J, Quadracci L. J, Striker G. E, and Harker L. A. 1974; A kinetic evaluation of hemostasis in renal disease. New England Journal of Medicine 291: 1111.
• 32 Gordon Y. B, McNeile A. T, Martin M. J, and Chard T. 1973; Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay. Lancet 2: 1168.
• 33 Grob P. J, Thòni R, and Schettlin W. 1971; Fibrinogenabbauprodukte im Urin nach Nierentransplantation. Schweizerische Medizinische Wochenschrift 101: 873.
• 34 Haanen C, Holdrinet A, and Wijdeveld P. 1971; a Intravascular clotting and acute renal failure. Scandinavian Journal of Haematology Suppl.13: 337.
• 35 Haanen C, Nováková L, Wijdeveld P, and van Liebergen F. 1971; b Significance of fibrin split products in patients with renal failure. Scandinavian Journal of Haematology Suppl.13: 345.
• 36 Habib R, Courtecnisse V, Leclerc F, Mathieu H, and Royer P. 1969; Etude an at omo-pathologique de 35 observations de syndrome hemoly tique et uremique de l’enfant. Archives Françaises de Pédiatrie 26: 391.
• 37 Hardaway R. M. 1966. Syndromes of disseminated intravascular coagulation. Thomas (ed.); Springfield:
• 38 Hawiger J, Niewiarowski S, Gurewich V, and Thomas D. P. 1970; Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. The Journal of Laboratory and Clinical Medicine 75: 93.
• 39 Hedner U. 1973; Urinary fibrin/fibrinogen degradation products (FDP) in renal diseases and during thrombolytic therapy. The Scandinavian Journal of Clinical & Laboratory Investigation 32: 175.
• 40 Hedner U. 1974 On fibrinolysis. A. Fibrin/fibrinogen degradation products with special reference to renal diseases. B. Inhibitors of activation of plasminogen. Thesis. University of Lund, Sweden. Studentlitteratur, Lund, Sweden.
• 41 Hedner U, Ekberg M, and Nilsson I. M. 1974; Urinary fibrin/fibrinogen degradation products (FDP) and glomerulonephritis. Acta Medica Scandinavica 195: 81.
• 42 Hedner U, and Nilsson I. M. 1971; Clinical experience with determination of fibrinogen degradation products. Acta Medica Scandinavica 189: 471.
• 43 Herschlein H. J, and Steichele D. F. 1968; Immunochemischer Nachweis von Fibrinogenderivaten im Urin bei Verbrauchskoagulopathien. Thrombosis et Diathesis haemorrhagica 19: 248.
• 44 Hulme B, and Pitcher P. M. 1973; Rapid latex-screening test for detection of fibrin/fibrinogen degradation products in urine after renal transplantation. Lancet 1: 6.
• 45 Hittton R. A, and O’Shea M. J. 1968; Haemostatic mechanism in uraemia. Journal of Clinical Pathology 21: 406.
• 46 Isacson S, and Nilsson I. M. 1969; The kidneys and the fibrinolytic activity in the blood. Thrombosis et Diathesis haemorrhagica 22: 211.
• 47 Ito T, Niwa T, and Matsui E. 1972; Fibrinolytic activity in renal disease. Clinica Chimica Acta 36: 145.
• 48 Katz D. H, Unanue E. R, and Dixon F. J. 1968; Induction of intravascular coagulation and focal tissue necrosis in rats by administration of anti-connective tissue antibodies. American Journal of Pathology 53: 835.
• 49 Kwaan H. C, and Fischer S. 1965; Localization of fibrinolytic activity in kidney tissues. Federation Proceedings 24: 387.
• 50 Larsson S. O, Hedner U, and Nilsson I. M. 1971; a On coagulation and fibrinolysis in conservatively treated chronic uraemia. Acta Medica Scandinavica 189: 433.
• 51 Larsson S. O, Hedner U, and Nilsson I. M. 1971; b On coagulation and fibrinolysis in acute renal insufficiency. Acta Medica Scandinavica 189: 443.
• 52 Larsson S. O, Hedner U, and Nilsson I. M. 1971; c On fibrinolytic split products in serum and urine in uraemia. Scandinavian Journal of Urology and Nephrology 5: 234.
• 53 Larsson S. O, Lindergârd B, Henriksson H, Hedner U, and Nilsson I. M. 1971; d A case of acute glomerulonephritis and severe uraemia treated with heparin and corticosteroids. Scandinavian Journal of Urology and Nephrology 5: 291.
• 54 Lieberman E. 1972; Hemolytic-uremic syndrome. Journal of Pediatrics 80: 1.
• 55 Luke B. G, Siegel B. B, Talbert W, and Holland N. 1970; Heparin treatment for post-partum renal failure with microangiopathic haemolytic anaemia. Lancet 2: 750.
• 56 McConnel D, Johnson J. G, Young I, and Holemans R. 1966; Localization of plasminogen activator activity in kidney tissue. Laboratory Investigation 15: 980.
• 57 McCluskey R. T, and Klassen J. 1973; Immunologically mediated glomerular, tubular and interstitial renal disease. New England Journal of Medicine 288: 564.
• 58 McKay D. G. 1965. Disseminated intravascular coagulation. An intermediary mechanism of disease. Hoeber Medical Division. Harper & Row, Publishers; New York, Everton, London:
• 59 McKay D. G, and Margaretten W. 1967; Disseminated intravascular coagulation in virus diseases. Archives of Internal Medicine 120: 129.
• 60 McNicol G. P, Barakat A. A, and Douglas A. S. 1965; Plasma fibrinolytic activity in renal disease. Scottish Medical Journal 10: 189.
• 61 McNicol G. P, Prentice C. R. M, Briggs J. D, and Pidgeon C. 1971; Fibrinogen degradation products (FDP) in renal disease: Estimation and significance of FDP in urine. Scandinavian Journal of Haematology Suppl.13: 329.
• 62 Marder V. J. 1971; Fibrinogen and fibrin degradation products. Physicochemical and physiological considerations. Thrombosis et Diathesis haemorrhagica Suppl.47: 85.
• 63 Marder V. J, and Shulman N. R. 1969; High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity. The Journal of Biological Chemistry 244: 2120.
• 64 Mauer S. M, Sutherland D. E. R, Howard R. J, Fish A. J, Najarian J. S, and Michael A. F. 1973; The glomerular mesangium. III. Acute immune mesangial injury: a new model of glomerulonephritis. Journal of Experimental Medicine 137: 553.
• 65 Melliger E. J. 1970; Detection of fibrinogen degradation products by use of antibody coated latex particles. Thrombosis et Diathesis haemorrhagica 23: 211.
• 66 Merskey C. 1971; Discussion. Scandinavian Journal of Haematology Suppl.13: 373.
• 67 Merskey C, Kleiner G. J, and Johnson A. J. 1966; Quantitative estimation of split products of fibrinogen in human serum. Relation to diagnosis and treatment. Blood 28: 1.
• 68 Morris R. H, Vassalli P, Beller F. K, and McCluskey R. T. 1964; Immuno-fluorescent studies of renal biopsies in the diagnosis of toxemia of pregnancy. Obstetrics and Gynecology 24: 32.
• 69 Naish P, Peters D. K, and Shackman R. 1973; Increased urinary fibrinogen derivatives after renal allotransplantation. Lancet 1: 1280.
• 70 Naish P. F, Sevitt L. H, Pitney W. R, and Peters D. K. 1970; Fibrinogen derivatives in renal disease. Clinical Science 39: 15.
• 71 Niléhn J.-E. 1967; Separation and estimation of “split products” of fibrinogen and fibrin in human serum. Thrombosis et Diathesis haemorrhagica 18: 487.
• 72 Nilehn J.-E. 1971; Quantitative immunochemical determination of degradation products of fibrinogen and/or fibrin with high voltage electrophoresis. Scandinavian Journal of Haematology Suppl. 13: 215.
• 73 Nussenzweig V, Seligmann M, Pelmont J, and Grabar P. 1961; Les produits de degradation du fibrinogène humain par la plasmine. I. Séparation et propriétés physico-chimiques. Annales de l’Institut Pasteur 100: 377.
• 74 Pandolfi M. 1967; Localization of fibrinolytic activity in the developing rat eye. Archives d’Ophtalmologie 78: 512.
• 75 Pandolfi M, Bergentz S.-E, Claes G, and Ljungqvist U. 1971 Localization of fibrinolytic activity in healthy and diseased renal tissue. 6th European Conference on Microcirculation, Aalborg 1970, p. 88.
• 76 Paronetto F, and Koffler D. 1965; Immunofluorescent localisation of immunoglobulins, complement and fibrinogen in human diseases. I. Systemic lupus erythematosus. Journal of Clinical Investigation 44: 1657.
• 77 Paronetto F, and Strauss L. 1962; Immunocytochemical observations in periarteritis nodosa. Annals of Internal Medicine 56: 289.
• 78 Preston F. E, Malia R. G, Blackburn E. K, and Platts M. 1971; FDP in glomerulonephritis. British Medical Journal 4: 171.
• 79 Rayner H, Paraskevas F, Israels L. G, and Israels E. D. 1969; Fibrinogen breakdown products: Identification and assay in serum and urine. The Journal of Laboratory and Clinical Medicine 74: 586.
• 80 Salaman J. 1972; Renal transplant rejection detected with I¹²⁵-fibrinogen. Proceedings of the Royal Society of Medicine 65: 476.
• 81 Semeraro N, Donati M. B, and Vermylen J. 1973 Detection of fibrinogen-related antigen in urine with two latex techniques. IV International Congress of the Society on Thrombosis and Haemostasis, Vienna, June 19—22.
• 82 Shah B. C, Ambrus J. L, Mink I. B, Albert D. J, Sampson D, and Murphy G. P. 1972; Fibrin degradation products in renal parenchymal disease states and renal transplant patients. Transplantation 14: 705.
• 83 Sharma S. D, Chugh K. S, Singh G. B, and Chhuttani P. N. 1967; Fibrinolytic activity of blood in uraemia. Indian Journal of Medical Research 55: 950.
• 84 Simon G, and Chatelanat F. 1963; Fibrine et fibrinoide dans les glomerulopathies. Etude comparée en pathologie expérimentale et spontanée. Pathology et Microbiology (Basel) 26: 191.
• 85 Starzl T, Lerner R, Dixon F, Growth C, Brettschneider L, and Terasaki P. 1968; Shwartzman reaction after human renal Homotransplantation. New England Journal of Medicine 278: 642.
• 86 Stiehm E. R, Kuplic L. S, and Uehling D. T. 1971; Urinary fibrin split products in human renal disease. The Journal of Laboratory and Clinical Medicine 77: 843.
• 87 Stiehm E. R, and Trygstad C. W. 1969; Split products of fibrin in human renal disease. American Journal of Medicine 46: 774.
• 88 Svanberg L, Hedner U, and Åstedt B. 1974; Value of determination of FDP during pregnancy by immunochemical and latex agglutination inhibition methods. Acta Obstetricia et Gynecologica Scandinavica 53: 81.
• 89 Thorell J, and Johansson B. G. 1971; Enzymatic iodination of polypeptides with ¹²⁵I to high specific activity. Biochimica et Biophysica Acta 251: 363.
• 90 Todd A. S. 1959; The histological localization of plasminogen activator. Journal of Pathology and Bacteriology 78: 281.
• 91 Vassalli P, and McCluskey R. T. 1965; The coagulation process and glomerular disease. American Journal of Medicine 39: 179.
• 92 Vassalli P, Morris R. H, and McCluskey R. T. 1963; The pathogenic role of fibrin deposition in the glomerular lesions of toxemia of pregnancy. Journal of Experimental Medicine 118: 467.
• 93 Vermylen J. 1974 Fibrinogen derivatives: their assessment and biological significance. Thesis. University of Leuven. ACCO Trénsestraat 134-316, B-3000 Leuven, Belgium.
• 94 Vermylen J, Dotremont G, Donati M. B, de Gaetano G, and Michielsen P. 1971; Pharmacological modification of urinary excretion of fibrinogen-like material in glomerulonephritis. Scandinavian Journal of Haematology Suppl.13: 365.
• 95 Vermylen J, Dotremont G, Donati M. B, Molla A, and Michielsen P. 1972 Urinary excretion of fibrinogen-fibrin related antigen in glomerulonephritis; effect of Indomethacin. Ill Congress of the International Society Thrombosis and Haemostasis, Washington, D.C. August 22-26.
• 96 Vreeken J, Boomgaard J, and Deggeller K. 1966; Urokinase excretion in patients with renal diseases. Acta Medica Scandinavica 180: 153.
• 97 Wardle E. N. 1973; Fibrinogen catabolism studies in patients with renal disease. Quarterly Journal of Medicine 165: 205.
• 98 Wardle E. N, Menon I. S, and Bastogi S. P. 1970; Study of proteins and fibrinolysis in patients with glomerulonephritis. British Medical Journal 2: 260.
• 99 Wardle E. N, and Kerr D. N. S. 1975; Radiofibrinogen catabolism in nephritis. British Medical Journal 1: 489.
• 100 Wardle E. N, and Taylor G. 1968; Fibrin breakdown products and fibrinolysis in renal disease. Journal of Clinical Pathology 21: 140.
• 101 Warren B. A. 1963; Fibrinolytic properties of vascular endothelium. British Journal of Experimental Pathology 44: 365.
• 102 Wilson C. B. 1972; Immunological mechanisms of glomerulonephritis. California Medicine 116: 47.
• 103 Yatzidis H. 1964; Evidence of fibrinogenuria in the nephrotic syndrome. Nature 201: 187.
• 104 Zühlke V, and Hermann G. 1970; Immunologische Untersuchungen der Proteinurie während Abstoßungskrisen nach allogenen Nierentransplantationen beim Menschen. Klinische Wochenschrift 48: 201.